Skip to main content

Advertisement

SpringerLink
Log in

Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Fibromyalgia (FM) is a syndrome characterized by chronic widespread pain and the presence of specific tender points. The prevalence of FM has been estimated at 2–7 % of the general global population. The presence of FM in several rheumatic diseases with a structural pathology has been reported as 11–30 %. The objectives of this study were to determine the prevalence of FM and to evaluate the possible relationship between FM existence and disease activity among rheumatic diseases. The study group included 835 patients—197 rheumatoid arthritis (RA), 67 systemic lupus erythematosus (SLE), 119 ankylosing spondylitis (AS), 238 osteoarthritis (OA), 14 familial Mediterranean fever (FMF), 53 Behçet’s disease (BD), 71 gout, 25 Sjögren’s syndrome (SS), 20 vasculitis, 29 polymyalgia rheumatica (PMR), and two polymyositis (PM)—with or without FM. Recorded information included age, gender, laboratory parameters, presence of fatigue, and disease activity indexes. The prevalence of FM in patients with rheumatologic diseases was found to be 6.6 % for RA, 13.4 % for SLE, 12.6 % for AS, 10.1 % for OA, 5.7 % for BD, 7.1 % for FMF, 12 % for SS, 25 % for vasculitis, 1.4 % for gout, and 6.9 % for PMR. One out of two patients with PM was diagnosed with FM. Some rheumatologic cases (AS, OA) with FM were observed mostly in female patients (p = 0.000). Also, there were significant correlations between disease activity indexes and Fibromyalgia Impact Questionnaire scores for most rheumatologic patients (RA, AS, OA, and BD) (p < 0.05; respectively, r = 0.6, 0.95, 0.887, and 1). Concomitant FM is a common clinical problem in rheumatologic diseases, and its recognition is important for the optimal management of these diseases. Increased pain, physical limitations, and fatigue may be interpreted as increased activity of these diseases, and a common treatment option is the prescription of higher doses of biologic agents or corticosteroids. Considerations of the FM component in the management of rheumatologic diseases increase the likelihood of the success of the treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28

    Article  CAS  PubMed  Google Scholar 

  2. Assumpção A, Cavalcante AB, Capela CE, Sauer JF, Chalot SD, Pereira CA, Marques AP (2009) Prevalence of fibromyalgia in a low socioeconomic status population. BMC Musculoskelet Disord 10:64

    Article  PubMed Central  PubMed  Google Scholar 

  3. Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M et al (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39(6):448–453

    Article  PubMed  Google Scholar 

  4. Yunus MB (2012) The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat. doi:10.1155/2012/584573

    Google Scholar 

  5. Hawker GA, French MR, Waugh EJ, Gignac MAM, Cheung C, Murray BJ (2010) The multidimensionality of sleep quality and its relationship to fatigue in older adults with painful osteoarthritis. Osteoarthr Cartil 18:1365–1371

    Article  CAS  PubMed  Google Scholar 

  6. Azevedo VF, Paiva ES, Felippe LRH, Moreira RA (2010) Occurrence of fibromyalgia in patients with ankylosing spondylitis. Bras J Rheumatol 50(6):646–654

    Google Scholar 

  7. Wolfe F, Petri M, Alarcón GS, Goldman J, Chakravarty EF, Katz RS, Karlson EW, Michaud K (2009) Fibromyalgia, systemic lupus erythematosus (SLE) and the evaluation of SLE activity. J Rheumatol 36(1):82–88

    PubMed Central  PubMed  Google Scholar 

  8. Pollard LC, Kingsley GH, Choy EH, Scott DL (2010) Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology 49:924–928

    Article  PubMed  Google Scholar 

  9. Ranzolin A, Brenol JCT, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, Xavier RM (2009) Association of concomitant fibromyalgia with worse disease activity score in 28 joints, Health Assessment Questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum 61(6):794–800

    Article  PubMed  Google Scholar 

  10. Melikoglu M, Melikoglu MA (2012) The prevalence of fibromyalgia in patients with Behçet’s disease and its relation with disease activity. Rheumatol Int. doi:10.1007/s00296-012-2530-1

  11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  CAS  PubMed  Google Scholar 

  12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    Article  CAS  PubMed  Google Scholar 

  13. Bennet PM, Wood PHN (1966) Recommendations—ankylosing spondylitis. In: Bennet PM, Wood PHN (eds) Population studies of the rheumatic diseases. International congress series no. 148. Excerpta Medica, Amsterdam, pp 456–457

  14. Altman RD (1991) Criteria for classification of clinical osteoarthritis. J Rheumatol 18(27):10–12

    Google Scholar 

  15. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879–1985

    Article  CAS  PubMed  Google Scholar 

  16. International Study Group for Behcet’s Disease (1990) Criteria for the diagnosis of Behcet’s disease. Lancet 335:1078–1080

    Google Scholar 

  17. Wallace SL, Robinson H, Masi AT, Decler JL, McCarty DJ, Yü TF (1977) Preliminary criteria for the classification of acute arthritis of primary gout. Arthritis Rheum 20:895–900

    Article  CAS  PubMed  Google Scholar 

  18. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–558

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Jenette JC, Falk RJ, Androssy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides: proposal of an interrational consensus conference. Arthritis Rheum 37:187–192

    Article  Google Scholar 

  20. Healey LA (1984) Long-term follow-up of PMR: evidence for synovitis. Semin Arthritis Rheum 13(4):322–328

    Article  CAS  PubMed  Google Scholar 

  21. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT (1982) Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 97(5):672–680

    Article  CAS  PubMed  Google Scholar 

  22. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344–347

    Article  CAS  PubMed  Google Scholar 

  23. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 33(2):160–172

    Article  CAS  PubMed  Google Scholar 

  24. Jahan F, Nanji K, Qidwai W, Qasim R (2012) Fibromyalgia syndrome: an overview of pathophysiology, Diagnosis and Management. Oman Med J 27(3):192–195

    Article  PubMed Central  PubMed  Google Scholar 

  25. Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12

    Article  CAS  PubMed  Google Scholar 

  26. Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733

    CAS  PubMed  Google Scholar 

  27. Garret S, Jenkinson T, Kennedy L, Whitelock H, Gaisford P, Calin A (1994) A new approach to deWning disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291

    Google Scholar 

  28. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25(4):280–284

    Article  PubMed  Google Scholar 

  29. Tuzun EH, Eker L, Aytar A, Daşkapan A, Bayramoğlu M (2005) Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthr Cartil 13(1):28–33

    Article  CAS  PubMed  Google Scholar 

  30. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15(12):1833–1840

    CAS  PubMed  Google Scholar 

  31. Mor A, Shinar Y, Zaks N, Langevitz P, Chetrit A, Shtrasburg S, Rabinovitz E, Livneh A (2005) Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 35(1):57–64

    Article  PubMed  Google Scholar 

  32. Bhakta BB, Brennan P, James TE, Chamberlain MA et al (1999) Behçet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology 38:728–733

    Article  CAS  PubMed  Google Scholar 

  33. Hamuryudan V, Fresko I, Direskeneli H, Tennant MJ et al (1999) Evaluation of the Turkish translation of a disease activity form for Behçet’s syndrome. Rheumatology 38:734–736

    Article  CAS  PubMed  Google Scholar 

  34. Arnold LM, Clauw DJ, McCarberg BH (2011) Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 86:457–464

    Article  PubMed Central  PubMed  Google Scholar 

  35. Wolfe F, Michaud K (2004) Severe rheumatoid arthritis, worse outcomes, comorbid illness and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol 31(4):695–700

    PubMed  Google Scholar 

  36. Wolfe F, Häuser W, Hassett AL, Katz RS, Walitt BT (2011) The development of fibromyalgia—I: examination of rates and predictors in patients with rheumatoid arthritis (RA). Pain 152:291–299

    Article  PubMed  Google Scholar 

  37. Valencia-Flores M, Cardiel MH, Santiago V, Resendiz M, Castaño VA, Negrete O, Rosenberg C, García-Ramos G, Alcocer J, Alarcón-Segovia D (2004) Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus. Lupus 13(1):4–10

    Article  CAS  PubMed  Google Scholar 

  38. Buskila D, Press J, Abu-Shakra M (2003) Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Allergy Immunol 25(1):25–28

    Article  PubMed  Google Scholar 

  39. Friedman AW, Tewi MB, Ahn C, McGwin G Jr, Fessler BJ, Bastian HM, Baethge BA, Reveille JD, Alarcón GS, LUMINA Study Group (2003) Systemic lupus erythematosus in three ethnic groups: XV prevalence and correlates of fibromyalgia. Lupus 12(4):274–279

    Article  CAS  PubMed  Google Scholar 

  40. Almodóvar R, Carmona L, Zarco P, Collantes E, González C, Mulero J et al (2010) Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Clin Exp Rheumatol 28(6 Suppl 63):33–39

    Google Scholar 

  41. Aloush V, Ablin JN, Reitblat T, Caspi D, Elkayam O (2007) Fibromyalgia in women with ankylosing spondylitis. Rheumatol Int 27(9):865–868

    Article  PubMed  Google Scholar 

  42. Giles I, Isenberg D (2000) Fatigue in primary Sjögren’s syndrome: is there a link with the fibromyalgia syndrome? Ann Rheum Dis 59:875–878

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Physical Medicine and Rehabilitation, Erzurum Regional Research and Training Hospital, 25240, Erzurum, Turkey

    Sema Haliloglu

  2. Department of Endocrinology, Erzurum Regional Research and Training Hospital, 25240, Erzurum, Turkey

    Ayse Carlioglu

  3. Department of Internal Medicine, Faculty of Medicine, Fatih University, 06510, Ankara, Turkey

    Derya Akdeniz

  4. Department of Rheumatology, Ankara Numune Research and Training Hospital, 06510, Ankara, Turkey

    Yasar Karaaslan

  5. Department of Hematology, Faculty of Medicine, Fatih University, 06510, Ankara, Turkey

    Ali Kosar

Authors
  1. Sema Haliloglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayse Carlioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Derya Akdeniz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasar Karaaslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ali Kosar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sema Haliloglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haliloglu, S., Carlioglu, A., Akdeniz, D. et al. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int 34, 1275–1280 (2014). https://doi.org/10.1007/s00296-014-2972-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-014-2972-8

Keywords

Search

Navigation